Hasil Pencarian  ::  Simpan CSV :: Kembali

"ABSTRAK Latar belakang: disglikemia adalah keadaan intoleransi glukosa berupa peningkatan kadar gula darah yang berhubungan dengan risiko penyakit kardiovaskular. Seiring dengan waktu, pada akhirnya diabetes akan menimbulkan kerusakan pada target organ, salah satu yang penting adalah pada sistem organ kardiovaskular, dapat berupa penyakit jantung koroner, kardiomiopati diabetes, penyakit serebrovaskuler, dan penyakit arteri perifer. Diabetes juga meningkatkan risiko terjadinya gagal jantung. Pada kardiomiopati diabetes, proses fibrosis yang masih reversibel sudah mulai terjadi bahkan ketika penderita masih asimtomatik. Pemeriksaan baku emas untuk mendeteksi terjadinya fibrosis miokard secara dini adalah pemeriksaan histopatologi jaringan miokardium melalui biopsi. Akan tetapi pemeriksaan ini sangat invasif dan tidak nyaman bagi subjek. Pemeriksaan yang kemudian berkembang adalah pencitraan menggunakan Cardiac Magnetic Resonance Imaging (CMRI). Akan tetapi pemeriksaan ini cukup mahal, dan tidak tersedia pada semua fasilitas kesehatan. Sementara itu, ST2 adalah penanda enzim jantung yang menggambarkan derajat proses fibrosis yang sedang terjadi pada miokard, terutama pada keadaan gagal jantung. Pemeriksaan menggunakan penanda enzim dapat menjadi alternatif dengan keuntungan lebih murah, dapat terjangkau luas dan mudah tersedia. Tujuan: Mengetahui hubungan antara kadar ST2 serum dengan fibrosis miokard interstisial pada penderita disglikemia. Metode: Pasien disglikemia yang lolos kriteria eksklusi berupa komorbid kardiovaskular akan menjalani pemeriksaan kadar ST2 serum dan T1 relaxation time menggunakan Cardiac MRI. Selanjutnya dilakukan analisis hubungan antara kadar ST2 serum dan T1 relaxation time. Hasil penelitian: Sebanyak 34 pasien diikutsertakan ke dalam penelitian ini. Didapatkan kisaran nilai kadar ST2 serum antara 12.40-53.22 ng/dL (median 19.95 ng/dL). Rerata nilai T1 relaxation time didapatkan sebesar 443.39 ± 113.35 ms. Terdapat korelasi bermakna antara kadar ST2 serum dengan fibrosis diffuse miokardium (Spearman correlation r = -0,547, p < 0.01). Pada analisa multivariat hubungan antara kadar ST2 serum dan T1 relaxation time tidak dipengaruhi oleh faktor perancu yang telah ditetapkan (r = -0,44, p = 0,033). Kesimpulan: Hasil penelitian ini menunjukkan kadar ST2 serum berkolerasi dengan fibrosis diffuse miokardium pada populasi disglikemia.ABSTRACT Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population.;Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population.;Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population.;Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population."

"Latar Belakang: COVID-19 di Indonesia menyebabkan kematian hingga lebih dari 150.000 orang. Salah satu populasi yang mengalami dampak dengan risiko kematian yang tinggi adalah populasi penyakit kardiovaskular. Severitas COVID-19 sering dikaitkan dengan rendahnya rasio PaO2/FiO2 dan tingginya kadar D-dimer. COVID-19 varian Omicron diketahui memiliki angka penyebaran yang lebih tinggi dengan severitas infeksi yang lebih rendah dibandingkan varian sebelumnya. Namun dampak jangka panjang pada pasien COVID-19 varian Omicron, khususnya pada populasi pasien dengan penyakit kardiovaskular masih menjadi pertanyaan. Penelitian ini ingin mengetahui dampak pasca COVID-19 varian Omicron dengan melihat kadar ST2 terlarut dan adanya gangguan paru yang dinilai dengan pemeriksaan spirometri.Tujuan: Penelitian ini dilakukan untuk mengetahui hubungan Rasio PaO2/FiO2 dan Kadar D-dimer pada saat admisi terhadap kadar ST2 terlarut dan gambaran spirometri pada pasien pasca COVID-19 varian Omicron dengan penyakit kardiovaskular. Metode: Penelitian berupa studi potong lintang terhadap pasien COVID-19 varian Omicron dengan riwayat komorbid penyakit kardiovaskular yang dirawat di Rumah Sakit Jantung dan Pembuluh Darah Harapan Kita. Diagnosis COVID-19 varian Omicron dilakukan dengan menggunakan metode WGS/SGTF. Pasien dengan kriteria inklusi menjalani pemeriksaan spirometri dan pengukuran kadar ST2 terlarut pada 6 bulan pasca perawatan.Hasil dan Pembahasan: Penelitian ini menunjukkan rasio PaO2/FiO2 dengan median 454 dan kadar D-dimer 790ng/mL. Mayoritas pasien menunjukkan gambaran gangguan resktriktif. Kadar ST2 terlarut pasca perawatan memiliki median 2716,8pg/mL. Tidak ditemukan adanya hubungan yang signifikan antara rasio PaO2/FiO2 dan kadar D-Dimer terhadap kadar ST2 terlarut maupun gambaran spirometri pada 6 bulan pasca COVID-19. Hal ini dapat dikaitkan dengan severitas COVID-19 yang lebih rendah sehingga tidak terdapat hubungan bermakna terhadap parameter admisi serta hubungan pengukuran 6 bulan pasca COVID-19 dengan kemungkinan adanya perbaikan fibrosis.Kesimpulan: Tidak ada hubungan yang signifikan antara rasio PaO2/FiO2 dan kadar D- Dimer terhadap kadar ST2 terlarut ataupun gambaran spirometri pada 6 bulan pasca COVID-19 varian Omicron.

---

Introduction: COVID-19 in Indonesia has caused more than 150,000 deaths. One of the affected populations with a high risk of death is the cardiovascular disease population. The severity of COVID-19 is associated with a low of PaO2/FiO2 ratio and the increased levels of D-dimer. Omicron variant is known to have higher transmission with less severe infection than the previous variant. However, research related to long term effect post COVID-19 with Omicron variant in cardiovascular population is not yet known.

Aim: This study was conducted to determine the relationship of PaO2/FiO2 ratio and D- dimer levels at admission to sST2 levels and spirometry profile in post COVID-19 variant Omicron patient with cardiovascular disease.

Method: Research in the form of a cross-sectional study was conducted on Omicron variant COVID-19 patients with a history of comorbid cardiovascular disease who were treated at the Harapan Kita Heart and Blood Vessel Hospital (RSJPDHK). The diagnosis of COVID-19 is carried out using the WGS/SGTF method. Patients undergo spirometry examination and measurement of sST2 levels at 6 month after hospitalization.

Results and Discussion: This study shows a PaO2/FiO2 ratio with a median of 454 with D-dimer levels 790 ng/mL. The majority of patients have a restrictive patterns. The median sST2 value in Omicron variant COVID-19 patients at 2716.8 pg/mL. There was no significant relationship between the ratio of PaO2/FiO2 and D-Dimer levels to sST2 levels and spirometry profile at 6 months after COVID-19 infection. This can be associated with lower COVID-19 severity so that there is no significant association with inflammatory parameters such as PaO2/FiO2 ratio and D-dimer levels, as well as the relationship between measurements 6 months post COVID-19 and the possibility of fibrosis improvement.

Conclusion: There was no significant relationship between the ratio of PaO2/FiO2 and D-Dimer levels to sST2 levels and spirometry abnormality at 6 months post COVID-19 variant Omicron."

"Latar Belakang: Penanda prognostik dapat menunjang tata laksana stroke iskemik (SI) akut. Protein neuroglobin (Ngb), yang berperan dalam transpor oksigen intrasel neuron dan mengurangi dampak hipoksia, adalah salah satu penanda potensial memenuhi fungsi tersebut.Metode: Studi potong lintang dilakukan pada pasien SI akut yang dirawat di RSUPN dr. Cipto Mangunkusumo pada Maret-April 2023. Sampel serum untuk pemeriksaan Ngb diambil pada tiga hari pasca awitan stroke, sedangkan modified Rankin scale (mRS), National Institutes of Health Stroke Scale (NIHSS), indeks Barthel (BI) dan Montreal Cognitive Assessment (MoCA-Ina) diperiksa pada hari ketujuh. Analisis kemaknaan dan kurva receiver operating characteristic (ROC) digunakan untuk mengetahui hubungan Ngb dengan luaran stroke iskemik akut.Hasil: Sebanyak 42 subjek menjalani analisis. Kadar Ngb serum lebih tinggi pada kelompok dengan skor mRS 3-6 dibandingkan 0-2 (12,42 ng/mL [3,57-50,43] vs 4,79ng/mL [2,25-37,32], p=0,005), dengan skor area di bawah kurva ROC sebesar 0,75. Kadar Ngb juga lebih tinggi pada kelompok dengan NIHSS pulang lebih tinggi (p=0,03), serta BI dan MoCA-Ina yang lebih rendah (p=0,01 dan p=0,002).Kesimpulan: Kadar Ngb serum pada SI akut yang lebih tinggi berkaitan dengan luaran fungsional jangka pendek yang lebih buruk. Penelitian lebih lanjut dibutuhkan sebelum terapan klinis.

---

Background: Prognostic markers can optimize the management of acute ischemic stroke (AIS). The neuroglobin (Ngb), which plays a role in intraneuronal oxygen transport and reduces the effects of hypoxia, is a marker that may perform this function.

Methods: A cross-sectional study was conducted on AIS patients who were treated at RSUPN dr. Cipto Mangunkusumo in March-April 2023. Serum samples for Ngb examination were taken three days after the onset of stroke, while modified Rankin scale (mRS), National Institutes of Health Stroke Scale (NIHSS), Barthel index (BI) and Montreal Cognitive Assessment (MoCA-Ina) were examined on the seventh day. Significance analysis and receiver operating characteristic (ROC) curve were used to determine the relationship between Ngb and AIS outcomes.

Results: A total of 42 subjects underwent analysis. Serum Ngb levels were higher in subjects with mRS score of 3-6 than 0-2 (12.42 ng/mL [3.57-50.43] vs 4.79 ng/mL [2.25-37.32], p=0.005). The area under the ROC curve score was 0.75. Ngb levels were also higher in the group with higher NIHSS at discharge (p=0.03), lower BI (p=0.01) and lower MoCA-Ina score (p=0.002).

Conclusion: Higher serum Ngb levels in AIS are associated with poorer short-term functional outcomes. Further research is needed before clinical application."

"Penyakit kardiovaskular menjadi masalah kesehatan global dan menempati urutan pertama penyebab kematian. Prevalensinya semakin meningkat seiring peningkatan faktor risiko diabetes melitus (DM), hipertensi, dislipidemia, dan merokok. Infark miokard akut (IMA) merupakan iskemia miokard yang disebabkan oleh ruptur plak arteri koroner yang menyebabkan trombosis dan oklusi. Upaya penanganan IMA dapat dilakukan dengan tindakan revaskularisasi, namun tindakan tersebut berpotensi menyebabkan cedera miokard ireversibel dan kematian kardiomiosit yang dikenal sebagai cedera iskemia reperfusi miokard. Mekanisme cedera iskemia reperfusi miokard menginduksi respons inflamasi yang memicu pembentukan inflamasom NLRP3 sehingga terjadi aktivasi kaspase-1 yang berperan pada maturasi dan pelepasan interleukin (IL)-18. Kolkisin merupakan obat antiinflamasi yang sederhana, murah, dengan masa kerja cepat yang dapat menghambat inflamasom, sehingga tidak terjadi aktivasi dan pelepasan IL-18. Penelitian mengenai efektivitas kolkisin terhadap penyakit kardiovaskular telah banyak dilakukan, namun penelitian mengenai perubahan kadar IL-18 pada pasien IMA belum banyak dilakukan. Penelitian ini bertujuan untuk mengkaji perubahan kadar IL-18 pada 48 jam pasca IKPP pada pasien IMA dengan elevasi segmen ST (EST) dengan pemberian kolkisin. Desain penelitian uji klinik tersamar ganda,  dengan total 60 pasien IMA-EST yang menjalani IKPP, terdiri dari 30 subjek kelompok kolkisin dan 30 subjek kelompok plasebo. Penurunan kadar IL-18 pada 48 jam pasca IKPP pada kelompok kolkisin lebih besar daripada kelompok plasebo, namun tidak didapatkan perbedaan bermakna antara keduanya. Perlu dilakukan penelitian lebih lanjut dengan berbagai rentang waktu untuk menilai penurunannya. 

Kata Kunci : IMA-EST, cedera iskemia reperfusi miokard, IL-18, kolkisin, penurunan kadar

---

Cardiovascular diseases have become a global health problem and are the leading cause of death. The prevalence is increasing due to the rise in risk factors such as diabetes mellitus (DM), hypertension, dyslipidemia, and smoking. Acute myocardial infarction (AMI) is myocardial ischemia caused by the rupture of a coronary artery plaque, leading to thrombosis and occlusion. The management of AMI can be done through revascularization procedures, but these interventions have the potential to cause irreversible myocardial injury and cardiomyocyte death, known as ischemia-reperfusion myocardial injury. The mechanism of ischemia-reperfusion myocardial injury induces an inflammatory response that triggers the formation of the NLRP3 inflammasome, leading to caspase-1 activation involved in interleukin (IL)-18 maturation and release. Colchicine is a simple, inexpensive, fast-acting anti-inflammatory drug that can inhibit the inflammasome, thus preventing the activation and release of IL-18. Studies on the effectiveness of colchicine in cardiovascular diseases have been conducted extensively, but research on changes in IL-18 levels in AMI patients is limited. This study aims to assess the changes in IL-18 levels within 48 hours post-primary percutaneous coronary intervention (PPCI) in ST-segment elevation myocardial infarction (STEMI) patients treated with colchicine. The study design is a double-blinded, randomized clinical trial, involving a total of 60 STEMI patients undergoing PPCI, with 30 subjects in the colchicine group and 30 subjects in the placebo group. The reduction in IL-18 levels at 48 hours post-PPCI in the colchicine group was greater than in the placebo group, although no significant difference was observed between the two groups. Further research with different time intervals is needed to assess the extent of IL-18 reduction.

Keyword : STEMI, ischemia-reperfusion myocardial injury, IL-18, colchicine, reduction levels"

"ABSTRAKPenyakit kardiovaskuler adalah penyakit serius yang mematikan di mana seperempat kematian yang terjadi ternyata disebabkan oleh penyakit ini. Sementara itu, di negara berkembang seperti Indonesia kualitas layanan kesehatan masih rendah, ditandai dengan kurangnya tenaga dokter pada daerah-daerah rural dan terpencil. Kondisi ini menjadi motivasi perlunya merancang inovasi teknologi telemedical yang berfungsi membantu dokter melakukan diagnosis dan pengobatan penyakit kardiovaskuler. Penelitian ini mengusulkan sebuah sistem berbasis teknologi machine-to-machine M2M untuk mengecek kesehatan pasien yang akan melaporkan hasilnya ke dokter jantung secara jarak jauh melalui aplikasi website dan aplikasi mobile, yang diberi nama My Kardio. Desain dari sistem ini adalah terdiri dari tiga bagian utama yaitu bagian pasien patient site yang terdiri dari sensor-sensor dan gateway, bagian server server site yaitu server aplikasi web dan mobile yang terletak di cloud internet, dan bagian dokter doctor site yaitu aplikasi web dan mobile untuk dokter agar dokter dapat melakukan pengecekan dan diagnosis terhadap pasien secara online. Sistem ini dilengkapi dengan sistem prediksi auto-rekomendasi untuk memberikan rekomendasi kepada dokter dalam menentukan diagnosis penyakit yang diderita pasien. Sistem auto-rekomendasi ini dibangun dengan algoritma k-Nearest Neighbors kNN yang terbukti cukup baik performansinya dalam hal akurasi dan kecepatan. Uji coba telah dilakukan pada empat lokasi di daerah pinggiran Jakarta yaitu Kampung Banjarsari 10 pasien , Cibubur 15 pasien , Cimanggis 37 pasien , dan Pancoran 23 pasien pada total sejumlah 85 pasien. Evaluasi kuantitatif menghasilkan rata-rata akurasi prediksi sistem auto-rekomendasi adalah 76,47 , waktu pemrosesan sistem auto-rekomendasi 1 detik, dan performansi waktu transfer data dari lokasi pemeriksaan ke server M2M adalah 8,97 detik. Evaluasi secara kualitatif dilakukan melalui wawancara dokter spesialis jantung, dan diperoleh hasil bahwa aplikasi My Kardio sangat membantu terutama untuk daerah-daerah yang kekurangan dokter spesialis jantung; dan juga bermanfaat untuk kota besar di mana akses pasien ke dokter jantung juga terkendala oleh waktu praktek dokter yang terbatas dan kemacetan. Kata kunci:Machine-to-machine, penyakit kardiovaskuler, k-Nearest Neighbors.

---

ABSTRACTCardiovascular disease is a deadly disease which one-fourth of deaths are caused by this disease. Meanwhile, in developing country like Indonesia, the quality of health services is still low, marked by the lack of doctors to serve patients. This condition gives the motivation about the need for a new innovation to improve the life expectancy of cardiovascular patients in Indonesia, with the help of technology. This research proposes a machine-to-machine M2M technology-based system to check the health of patients which will report the results to the cardiologist remotely through the web and mobile applications, named My Kardio. The design of this system is composed of three main parts, the first one is patient site consisting of sensors and gateways, then server site which is web and mobile application server located in the Internet cloud, and the last is doctor site: web and mobile application for doctors to enable doctors checking and diagnosing patients online. The system is equipped with an auto - recommendation prediction system to provide recommendations to physicians in determining the diagnosis of illness suffered by the patient. This auto-recommendation system is built on the k-Nearest Neighbors kNN algorithm that has been proven with good accuracy and fast. Trials have been performed in four locations in the suburbs of Jakarta: Kampung Banjarsari 10 patients , Cibubur 15 patients , Cimanggis 37 patients , and Pancoran 23 patients of the total 85 patients. Quantitative analysis results are, first the prediction accuracy of the auto- recommendation system is 76.47 on average, then the processing time of auto- recommendation system is 1 second, and last, the duration of data transfer time from location to M2M server is 8.97 seconds. Qualitative analysis was made with cardiologists interviews, which results that My Kardio application is very helpful especially in remote areas which lacking of cardiologists, even for big cities where patients rsquo; access to cardiologists is a problem due to limited clinic time and traffic jams. "

"Latar Belakang: Penyakit jantung merupakan penyebab kematian nomor satu dari kelompok Penyakit Tidak Menular (PTM) dan berdasarkan studi epidemiologi di Asia Tenggara, prevalensi gagal jantung di Asia Tenggara memiliki presentase yang lebih tinggi dibandingkan dengan negara lainnya. Gagal Jantung Dekompensasi Akut (GJDA) menjadi indikasi utama terjadinya admisi pada pasien dengan gagal jantung, khususnya gagal jantung dengan fraksi ejeksi rendah. Adanya kondisi hiponatremia dan hipokloremia pada pasien fraksi ejeksi rendah diharapkan dapat meningkatkan kewaspadaan bagi klinisi sebagai prediktor admisi akibat GJDA. Metode : Studi kohort retrospektif dengan menelusuri rekam medis pasien GJDA pada populasi fraksi ejeksi rendah berusia>18 tahun yang dirawat inap di RSUPN Cipto Mangunkusumo sejak tahun 2020 sampai dengan tahun 2023, dan menelusuri data elektrolit 90 hari sebelum admisi pasien dengan diagnosis GJDA pada pasien dengan fraksi ejeksi rendah. Dilakukan analisis bivariat dan juga multivariat prediktor admisi dengan diagnosis GJDA pada pasien dengan fraksi ejeksi rendah.Hasil : Dari total 265 subjek penelitian yang diletiti, analisis bivariat yang menunjukkan hiponatremia dan hipokloremia dapat menjadi prediktor admisi akibat GJDA pada pasien dengan fraksi ejeksi rendah, dengan analisis multivariat menunjukkan keduanya tetap merupakan prediktor yang baik secara statistik terkait admisi akibat GJDA pada pasien dengan fraksi ejeksi rendah dengan RR hiponatremia 1,729 (IK95% 1,367-2,179) dengan nilai P<0,001 dan OR hipokloremia 1,181 (IK95% 1,064-1,311) dengan nilai P 0,002.Kesimpulan : Hipontaremia ataupun hipokloremia pada pasien gagal jantung dengan fraksi ejeksi rendah dapat menjadi prediktor admisi akibat GJDA.

---

Background : Cardiovascular disease remains the foremost cause of mortality within the spectrum of Non-Communicable Diseases (NCDs). Epidemiological studies within Southeast Asia have illuminated a notably elevated prevalence of heart failure compared to other global regions. Acute Decompensated Heart Failure (ADHF) serves as a primary catalyst for hospital admissions, particularly among patients exhibiting diminished left ventricular ejection fraction. The identification of hyponatremia and hypochloremia in individuals with reduced ejection fraction holds promise in enhancing clinicians' vigilance as predictive markers for ADHF admissions.

Methodology : This retrospective cohort study delved into the medical records of individuals with ADHF within the low left ventricular ejection fraction cohort, aged >18 years, admitted to Dr. Cipto Mangunkusumo National Central General Hospital from 2020 to 2023. Electrolyte profiles from the 90-day period preceding ADHF diagnosis among patients with reduced ejection fraction were scrutinized. Both bivariate and multivariate analyses were conducted to delineate predictors of ADHF admissions in this subgroup.

Results : Among the 265 subjects scrutinized, bivariate analysis revealed that both hyponatremia and hypochloremia could function as robust predictors for ADHF admissions in patients displaying diminished ejection fraction. Multivariate analysis solidified their statistical significance as predictors of ADHF admissions in individuals with reduced ejection fraction. Hyponatremia exhibited an relative risk (RR) of 1.729 (95% CI 1.367-2.179) with a P-value of <0.001, while hypochloremia demonstrated an RR of 1.181 (95% CI 1.064-1.311) with a P-value of 0.002.

Conclusion : The presence of hyponatremia and hypochloremia in patients with heart failure and reduced left ventricular ejection fraction stands as a clinically significant predictive factor for ADHF admissions."

"Kejadian penyakit kelainan katup masih menjadi masalah dan angka kejadiannya terus mengalami peningkatan di negara berkembang termasuk di Indonesia Dari tahun ke tahun angka kesakitan dan kematian terus mengalami peningkatan seiring dengan tingginya angka kejadian demam rematik di negara dengan iklim tropis dan subtropis Selain itu karena berbagai faktor lainnya seperti ekonomi dan lingkungan Kelainan katup stenosis mitral dapat menyebabkan berbagai komplikasi termasuk diantaranya gagal jantung dan edema paru Perawat sebagai salah satu tenaga kesehatan yang paling penting di unit pelayanan kesehatan diharapkan mampu mendeteksi secara dini timbulnya komplikasi yang akan muncul akibat penyakit jantung Sedangkan perawat spesialis sangat berperan penting dalam memberikan asuhan keperawatan kepada pasien terutama pasien dengan penyakit kardiovaskular yang kompleks Praktik residensi keperawatan medikal bedah bertujuan untuk melaksanakan peran perawat spesialis yang mencakup pemberian asuhan keperawatan dengan pendekatan konsep konservasi Myra Estrin Levine pada pasien dengan gangguan sistem kardiovaskular terutama pada pasien dengan stenosis katup mitral penerapan tindakan pemberian latihan aktifitas fisik rehabilitasi jantung fase 1 untuk mempercepat proses penyembuhan dan stabilisasi status hemodinamik serta berperan aktif dalam program inovasi pengembangan media edukasi pada pasien dengan pemasangan alat medis Hasil analisis praktik menunjukkan bahwa model konservasi Levine dapat diterapkan pada pasien dengan gangguan kardiovaskular untuk mengoptimalkan derajat kesehatan pasien pemberian latihan aktifitas fisik rehabilitasi jantung fase 1 menunjukkan tidak ada perubahan yang signifikan dalam perubahan hemodinamik dan pengembangan media edukasi pada pasien dengan pemasangan alat medis membantu pasien dalam meningkatkan pengetahuan mengenai alat medis.

---

Incidence of cardiac valve abnormalities still a problem and the number of events is increasing in developing countries including Indonesia From year to year the morbidity and mortality continues to increase in line with by a high incidence of rheumatic fever in countries with tropical and subtropical climates Moreover because of many other factors such as the economy and environment Abnormalities of the mitral valve stenosis can cause a variety of complications including heart failure and pulmonary edema The nurse as one of the most important health personnel in the health care unit is expected to detect early onset of complications that would arise as a result of valve disease Meanwhile nurse specialist plays an important role in providing nursing care to patients especially patients with complicated cardiovascular disease

The practice of medical surgical nursing residency aimed to carry out the role of nurse specialist includes providing nursing care by implementing the concept of conservation of Myra Estrin Levine to patients with cardiovascular disorders especially those with mitral valve stenosis The implementation of measures to provide cardiac rehabilitation exercise physical activity to accelerate the phase 1 healing process and stabilization of hemodynamic status as well as an active role in the development of educational media innovation program in patients with implanted medical devices

Results of the analysis showed that the model of conservation practices Levine can be applied in patients with cardiovascular disorders to optimize the health status of patients provision of cardiac rehabilitation exercise physical activity Phase 1 showed no significant changes in hemodynamic changes and the development of educational media in patients with implanted medical devices help patients to improve knowledge of medical devices."

"Latar Belakang : Infeksi COVID-19 telah diketahui masih dapat menyebabkan gejala sampai 90 hari dan bahkan lebih, meski infeksi akutnya telah berlalu. Hal ini disebabkan karena adanya fenomena sindroma pasca COVID-19. Mekanisme kejadian tersebut sampai saat ini masih belum diketahui pasti. Hal tersebut diduga kuat akibat adanya fibrosis di beberapa organ, terutama jantung dan paru. Sementara itu, beberapa studi telah menyebutkan bahwa sST2 merupakan penanda fibrosis jantung. Meskipun demikian, sampai saat ini belum ada penelitian yang mencoba mengetahui faktor-faktor apa saja yang memiliki hubungan dengan kejadian fibrosis pasca infeksi COVID-19. Kadar sST2 pada pasien komorbid kardiovaskular tanpa COVID-19 dan populasi orang sehat, khususnya di Indonesia juga belum diketahui.Tujuan : Mengetahui perbandingan kadar sST2 pada pasien komorbid kardiovaskular 12 minggu pasca infeksi COVID-19 dengan pasien komorbid kardiovaskular tanpa COVID-19 dan populasi orang sehat, serta hubungannya dengan faktor-faktor admisi.Metode : Penelitian ini merupakan studi observasional potong lintang. Kadar sST2 pada pasien 12 minggu pasca infeksi COVID-19 dibandingkan dengan komorbid kardiovaskular akan dibandingkan dengan kelompok kontrol, yaitu kontrol 1 yang merupakan pasien komorbid kardiovaskular tanpa COVID-19 dan kontrol 2 yang merupakan populasi orang sehat. Kelompok kontrol dipilih menggunakan metode matching. Hubungan faktor klinis dan laboratoris saat dengan kadar sST2 pada pasien 12 minggu pasca infeksi COVID-19 dianalisis menggunakan analisis multivariat.Hasil : Terdapat 162 subjek yang menyelesaikan rangkaian penelitian yang terdiri atas 100 subjek dengan penyintas COVID-19 disertai komorbiditas kardiovaskular (kelompok kasus), 31 subjek dengan komorbiditas kardiovaskular tanpa COVID-19 (kelompok kontrol 1), dan 31 subjek sehat tanpa riwayat COVID-19 dan komorbiditas kardiovaskular (kelompok kontrol 2). Ketiga kelompok memiliki karakteristik yang sama. Terdapat perbedaan signifikan rerata nilai sST2 antara kelompok kasus dibandingkan kontrol 1 dan kontrol 2 (2786 ± 73 vs 2666 ± 162 pg/l, p <0.001 dan 2786 ± 73 vs 2517.15 ± 321 pg/l, p < 0.001), serta kontrol 1 dibandingkan kontrol 2 (2666 ± 162 pg/l vs 2517.15 ± 321 pg/l, p < 0.001). Analisis multivariat menunjukkan PaO2 (p < 0.001) dan nilai CT (p = 0.04) memiliki hubungan dengan kadar sST2 pada pasien 12 minggu pasca infeksi COVID-19.Kesimpulan : Terdapat perbedaan signifikan antara kadar sST2 sebagai penanda fibrosis jantung pada ketiga kelompok subjek penelitian, dengan kadar sST2 lebih tinggi pada subjek dengan penyintas COVID-19 disertai komorbiditas kardiovaskular. Terdapat hubungan PaO2 dan nilai CT saat admisi dengan kadar sST2.

---

Background : Recent findings showed that symptoms associated with COVID-19 infection may persist up to 90 days even after the acute disease period has passed. This condition is now termed as post COVID-19 syndrome. Several pathophysiologic mechanisms of this event had been proposed, all of which still needed further elaboration. One of the proposed mechanisms involves fibrotic processes in several organs, especially heart and the lungs. SST2 has been suggested as a novel biomarker for cardiac fibrosis. However data are still needed to further elucidate the factors which are associated with the incidence of fibrosis post COVID-19 infection. Furthermore, data regarding sST2 levels in patients with cardiovascular comorbidities and in healthy subjects are still limited.

Objective : Knowing the differences on sST2 levels between subjects with cardiovascular comorbidities 12 weeks post COVID-19 infection, those without history of COVID-19 but with cardiovascular comorbidities, and healthy population, as well as knowing its relationship with admission factors.

Methods : This study is a cross-sectional observational study on patients 3 months after COVID-19 infection presented with cardiovascular comorbidities. Age and sex-matched control groups were used as comparison. The results were compared with a group without history of COVID-19 and healthy populations. Relationship between admission factors was assessed using multivariate analysis

Results : 162 subjects completed the study series, consisting of 100 subjects with COVID-19 survivors with cardiovascular comorbidities (case group), 31 subjects with cardiovascular comorbidities without COVID-19 (control group 1), and 31 healthy subjects without a history of COVID-19 and cardiovascular comorbidities (control group 2). All three groups had similar characteristics. There was a significant difference in the mean sST2 value between the case groups compared to control 1 and control 2 (2786 ± 73 vs 2666 ± 162 pg/l, p < 0.001 and 2786 ± 73 vs 2517.15 ± 321 pg/l, p < 0.001 respectively), and control 1 compared to control 2 (2666 ± 162 pg/l vs 2517.15 ± 321 pg/l, p < 0.001). Multivariate analysis revealed PaO2 (p < 0.001 and CT values (p = 0.04) as admission factor associated with increased sST2 3 months after initial COVID-19 infection.

Conclusion : SST2 levels were found to be significantly different between the three groups, with the highest level on the case group (subjects with history of COVID-19 and cardiovascular comorbidities). Factors upon admissions which include Arterial oxygen partial pressure (PaO2) (p < 0.001) and CT value (p = 0.04) were found to be associated with increased sST2 levels."

"Penyakit kardiovaskular merupakan salah satu penyebab utama kematian di Indonesia. Low Density Lipoprotein (LDL) adalah salah satu profil lemak yang memengaruhi kejadian penyakit kardiovaskular. Penelitian ini bertujuan untuk mengetahui efek buah Garcinia atroviridis sebagai alternatif terapi untuk menurunkan kadar LDL. Penelitian ini merupakan studi eksperimental, perlakuan terhadap hewan coba tikus, dibagi dalam kelompok propylthiouracil (PTU)+diet tinggi lemak, kelompok PTU, dan pemberian 3 kelompok ekstrak. Induksi dengan asupan tinggi lemak (0,375 ml gajih ayam dan 1,5 ml kuning telur puyuh) dan PTU pada kelompok PTU+diet tinggi lemak dan 3 kelompok ekstrak. Pengambilan sampel darah pada tikus PTU dan PTU+diet tinggi lemak setelah 21 hari, dan 42 hari pada kelompok ekstrak. Data dianalisis menggunakan tes parametrik one way ANOVA dan uji T tidak berpasangan. Didapatkan rata-rata LDL tiap perlakuan: (1) PTU (24,8), (2) PTU+diet tinggi lemak (52,4), (3) dosis 10 mg (22,8), (4) dosis 20 mg (25,4), (5) dosis 30 mg (36,25). Pada uji T menunjukkan kenaikan LDL yang signifikan pasca induksi, pada uji ANOVA menunjukkan penurunan LDL pasca pemberian ekstrak buah Garcinia atroviridis yang berbeda bermakna. Analisis Post Hoc menunjukkan penurunan LDL paling signifikan pada dosis 10 mg. Disimpulkan bahwa pemberian ekstrak buah Garcinia atroviridis pada tikus strain Wistar secara signifikan menurukan kadar LDL.

---

Cardiovascular disease is one of the leading cause of death in Indonesia. Low Density Lipoprotein (LDL) is one of lipid profile that has effect on cardiovascular disease. This research is aimed to discover the effect of Garcinia atroviridis fruit extract to lower LDL level. This is an experimental study, intervention was given differently to laboratory rats: propylthiouracil (PTU)+high lipid diet, PTU, and 3 extract groups. Induction is conducted with high lipid diet (0,375 ml chicken fat and 1,5 ml quail egg yolk) and PTU, in PTU with high lipid diet and 3 extract groups. Rats blood was extracted, PTU and PTU+high lipid diet after 21 days, and 42 days for extract group.

Data was analysed using one way ANOVA parametric test and independent T test. Mean LDL value of each treatment: (1) PTU (24,8), (2) PTU+high lipid diet (52,4), (3) 10 mg (22,8), (4) 20 mg (25,4), (5) 30 mg (36,25). T test showed significant result in increasing LDL level after induction and ANOVA test showed significant result in lowering LDL level after given Garcinia atroviridis fruit extract. Post Hoc analysis shows the most significant result comes from 10 mg dose. In conclussion, Garcinia atroviridis fruit extract significantly lowers blood LDL of Wistar strain rats."

"Penyakit kardiovaskular merupakan penyebab kematian nomor satu di dunia dengan angka kejadian yang terus bertambah. Salah satu faktor resiko dari penyakit ini adalah hipertrigliserida. Penelitian ini merupakan studi eksperimental yang ditujukan untuk mengetahui metode induksi peningkatan kadar trigliserida, dan efektifitas ekstrak buah Garcinia atroviridis sebagai antitrigliserida. Penelitian terbagi menjadi 2, pertama untuk mencari metode induksi, untuk membuktikan efektifitas ekstrak buah Garcinia atroviridis. Penelitian pertama terdiri dari kelompok tinggi lemak diberikan diet tinggi lemak (0,375ml gajih ayam, 1,5ml kuning telur puyuh, dan 1ml PTU) dan kelompok tanpa lemak diberikan diet standar dan PTU. Penelitian kedua terdiri dari kelompok uji diberikan diet tinggi lemak dengan jumlah yang sama ditambah dengan ekstrak buah Garcinia atroviridis dalam 3 dosis (10mg, 20mg, 30mg). Setiap kelompok tersebut kemudian dilakukan pemeriksaan kadar trigliserida darah. Hasilnya diuji dengan tes parametrik t-test untuk menguji metode induksi, dan one way ANOVA untuk menguji efektifitas ekstrak. Terdapat perbedaan tidak signifikan (p=0,255). Pada kelompok ekstrak didapatkan perbedaan yang signifikan pada kelompok uji 1a, dan 1c (p=0,006). Maka dapat disimpulkan bahwa terdapat efek yang signifikan dari ekstrak buah Garcinia atroviridis untuk menurunkan kadar trigliserida berdasarkan dosis pada darah tikus strain Wistar yang diberi asupan lemak berlebih.

---

Cardiovascular diseases, the world?s number one cause of death has certainly keep increasing. One of the risk factor is hypertriglyceride. This study is an experimental based study which was conducted to learn induction method to increase triglyceride level, and the effect of extract Garcinia atroviridis fruit extract as antitriglyceride.

This study was separated into 2, first to look for induction method, second to prove the effect of Garcinia atroviridis fruit extract. The first study consists of high-fat group that was given high fat diet (0,375ml fatty portion of chicken meat; 1,5ml quail's egg yolk; and 1ml PTU) and non-fat group, that was given standard diet and 1ml PTU. The second study consists of group treatments, which were given high fat diet and extract of Garcinia atroviridis fruit in 3 doses (10mg, 20mg, 30mg). Each group then examined for their triglyceride level.

The results were analyzed using t-test for induction method and one-way ANOVA test for the effect of extract There are no significance different between groups without extract (p=0,255). In groups with extract, there?s a significance difference between groups (p=0,006). Therefore it concluded that there are significance effect of Garcinia atroviridis fruit extract in reducing triglyceride level in Wistar strain rats blood."